Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. - Wikidata - awgldk - TriplyDB

Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling.

Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling.

http://www.wikidata.org/entity/Q33710814

about

Cell based therapies for ischemic stroke: from basic science to bedside Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis Preconditioning stem cells for in vivo delivery.Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardium Stem cells for cardiac repair: status, mechanisms, and new strategies.Freeze-dried rat bone marrow mesenchymal stem cell paracrine factors: a simplified novel material for skin wound therapy Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease.Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease Adipose Mesenchymal Stem Cell Secretome Modulated in Hypoxia for Remodeling of Radiation-Induced Salivary Gland Damage Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine.Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration.Preconditioning strategy in stem cell transplantation therapy.Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.Mesenchymal stem cells and vascular regeneration.Diazoxide protects L6 skeletal myoblasts from H2O2-induced apoptosis via the phosphatidylinositol-3 kinase/Akt pathway.Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function TNF-α promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts.Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells.Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs).Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.Diazoxide pretreatment enhances L6 skeletal myoblast survival and inhibits apoptosis induced by hydrogen peroxide.Diazoxide preconditioning of endothelial progenitor cells improves their ability to repair the infarcted myocardium.

P2860

Q27025754-BC732FFB-8151-4D50-B22F-D1EDA3E3533E Q28075643-9950AE52-8EB4-469E-AFB6-980E50F9AE84 Q33998015-285C7E52-A47E-4D7F-8CAD-A9665EFBDCAF Q34212214-6CD49EFA-7FC5-4D49-946E-43CA2C60E0EB Q35061251-81E157DD-D479-43A8-93D4-D1E958920E14 Q35109987-6FE28FFD-E1A8-4A41-BA7A-6A3A2C67004A Q35167303-23FF98E8-5BBF-46F7-AC55-C0FA63C01FCE Q35287851-43FFE993-AF14-465B-BCEC-4E1E6ED47769 Q35804026-7FEEFDFF-1005-40AA-8442-4732D0B82D5C Q35830634-C5495547-FD4D-4F90-92CA-5C9292F3EB3B Q35849951-E588FD19-03DB-41DF-869F-DA46C4FD3040 Q35949645-BFC82937-72E4-45BE-9478-B7F4408490A1 Q37097008-4251B9D6-9D93-4D83-9557-2E67DF37DE6A Q37153287-41EB90EF-E22E-49E7-BA58-4FDEB29EE04F Q38005087-53DB913F-6DEC-4939-8DEF-6E1199972B2C Q38097512-74AA6DF8-CA29-47A0-964C-6A76E3AF758B Q38126494-6A20B201-9335-4AA2-A924-13920B067D44 Q38214941-B5361682-6563-4E7A-BEAA-21B7E4A2A0B9 Q38742380-F96B0B8A-66B2-4F96-A8EA-434B2DDF3823 Q38816740-9A7C7F28-9413-4FE9-B7D6-906520EA00E0 Q38822862-93A33C97-555E-495A-B86B-2570A606EEFE Q39923212-5DDEB802-FD2B-4DDC-B040-88296C65C296 Q41520357-C1CA294F-3F2A-4874-86C1-53D16C42B3B5 Q42137721-6A277D1C-B487-4799-81FA-3A628C7FA6AF Q42548312-8EDB91DD-816D-447D-8F01-CAC5E0AE77CA Q44298061-EB967B1A-8F51-4D52-A2ED-B73ACB684AFC Q49178540-7197814D-D55A-4E7C-A05F-28C0283A0EEE Q50437302-73C01441-DBEC-4DF8-AAA5-EF1340F2258F Q50462523-DD82C06C-C5A8-4323-BCC3-2B6453486CBF Q53190888-E898921B-80D2-45C0-B4BE-7A6C84405EA7 Q53484210-B6F2D72D-3EF7-47F0-AEDE-6CFCD24F3854

P2860

Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling.

http://www.wikidata.org/entity/Q33710814

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@ast

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@en

type

label

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@ast

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@en

prefLabel

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@ast

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@en

P1433

Q33710814-40B89F0D-652A-48EE-9B31-12046E937471

P1476

Q33710814-52AC8F06-DEB2-410C-9ACD-4219C83BD83A

P2093

Q33710814-05F70AB6-E28E-4BF5-8D42-113135440DE9

Q33710814-1BDFA04B-6412-45EC-BE04-C3CB2AB97EB7

Q33710814-842925D1-3242-4C00-AE92-FCAA7832FE8F

Q33710814-CA74F453-92E7-44CF-ACE6-137DDE417CF6

Q33710814-D82AD363-7483-41BF-8A28-88C289E27F2B

Q33710814-E3DAC69C-4BE0-4764-A2B0-5C57C7F37D25

P2860

Q33710814-03DAAC2D-1EAF-4B95-BE30-B900FF864522

Q33710814-06D0085B-8E18-4EBB-88B0-D064BFBD24AB

Q33710814-0A08D05E-9EAE-4836-908F-6D8511DA8F57

Q33710814-0BCD7A2E-67CC-4D9B-8D4D-2F20FBC22B4E

Q33710814-26BF3CE5-DEB5-4C19-AFE7-ABF5CC0D4802

Q33710814-36B6F00B-CEDE-4846-A32B-76ACD2A8B57D

Q33710814-390D3850-B7E8-4500-96BA-EDC6DF4BB4F5

Q33710814-4E902473-DBF3-4BD9-B96B-5966B72CCA98

Q33710814-56C3A525-3998-4D15-849A-E2BCAB9E4C5D

Q33710814-5D437179-558A-4F5F-B7A6-112BEC27DAA7

P304

Q33710814-11F9DB32-C49F-4840-802B-DF60C10DD794

P31

Q33710814-AB2E4D35-5A30-4575-9386-04144DF849EF

P356

Q33710814-15C1A7D4-24FA-4A92-A04E-4454E80A431E

P433

Q33710814-BFD1A263-104B-4893-9256-AD6FB2BB661E

P478

Q33710814-CE977C91-E699-44D0-B4E3-FA6EA00E4EFC

P577

Q33710814-035525E8-AF3F-4F13-AF64-910C54E24ADE

P5875

Q33710814-3E92D665-FB45-46CB-B127-71372C1CBE7C

P698

Q33710814-94AC84EF-5C7E-492A-A633-4DAC06EF3DED

P932

Q33710814-216409FB-D786-40AB-98A8-9E36750B7ED2

P356

P1433

Antioxidants & Redox Signaling

P1476

Preconditioning promotes survi ...... heart via NF-kappaB signaling.

@en

P2093

Husnain Kh Haider

http://www.w3.org/2001/XMLSchema#string

Muhammad Ashraf

http://www.w3.org/2001/XMLSchema#string

Muhammad R Afzal

http://www.w3.org/2001/XMLSchema#string

Niagara Muhammad Idris

http://www.w3.org/2001/XMLSchema#string

Rafeeq P H Ahmed

http://www.w3.org/2001/XMLSchema#string

Shujia Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

Nuclear factor-kappaB in cancer development and progression

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

NF-kappaB at the crossroads of life and death

The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Regulating the regulator: NF-kappaB signaling in heart.

Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.

Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators.

P304

693-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2009.2755

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26809194

http://www.w3.org/2001/XMLSchema#string

P698

19751147

http://www.w3.org/2001/XMLSchema#string

P932

2834442

http://www.w3.org/2001/XMLSchema#string